Brendel Financial Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,831
Closed -$110K 74
2023
Q4
$110K Hold
11,831
0.07% 89
2023
Q3
$120K Sell
11,831
-50
-0.4% -$597 0.18% 41
2023
Q2
$149K Buy
+11,881
New +$141K 0.22% 41

Other funds holding HCAT

Brendel Financial Advisors's HCAT Position: Q1 2024 in Review

Brendel Financial Advisors sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 11,831 shares — an estimated $110K sold.

Brendel Financial Advisors first reported a position in HCAT in Q2 2023 and held it in 3 quarters. The position peaked at $149K in Q2 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Brendel Financial Advisors reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Brendel Financial Advisors sold 11,831 Health Catalyst shares in Q1 2024, an estimated $110K.
  • Brendel Financial Advisors first reported a position in Health Catalyst in Q2 2023 and held it in 3 quarters.
  • Brendel Financial Advisors's Health Catalyst position peaked at $149K in Q2 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Brendel Financial Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.